...
cmmb-img

Chemomab Therapeutics Ltd DRC, Common Stock

CMMB

NAQ

$1.68

+$0.06

(3.7%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$30.55M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
40.23K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.30
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.45 L
$2.55 H
$1.68

About Chemomab Therapeutics Ltd DRC, Common Stock

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is CM-101, a humanized monoclonal antibody attenuates the basic function of CCL24 that is in phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCMMBSectorS&P500
1-Week Return6.33%-2.12%-3%
1-Month Return2.44%-3.42%-0.73%
3-Month Return-1.75%-11.13%2.87%
6-Month Return80.65%-5.74%7.17%
1-Year Return230.06%3.97%25.31%
3-Year Return-73.79%1.05%28.38%
5-Year Return-92.61%34.37%81.89%
10-Year Return-99.03%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue281.00K80.00K34.02K57.77K66.83K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":28.47,"profit":true},{"date":"2021-12-31","value":12.11,"profit":true},{"date":"2022-12-31","value":20.56,"profit":true},{"date":"2023-12-31","value":23.78,"profit":true}]
Gross Profit(281.00K)(80.00K)(34.02K)(57.77K)(66.83K)[{"date":"2019-12-31","value":-28100000,"profit":false},{"date":"2020-12-31","value":-7999900,"profit":false},{"date":"2021-12-31","value":-3402300,"profit":false},{"date":"2022-12-31","value":-5777300,"profit":false},{"date":"2023-12-31","value":-6682700,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses22.90M5.97M12.37M28.53M25.46M[{"date":"2019-12-31","value":80.25,"profit":true},{"date":"2020-12-31","value":20.93,"profit":true},{"date":"2021-12-31","value":43.34,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":89.23,"profit":true}]
Operating Income27.12M(5.97M)(12.40M)(28.53M)(25.46M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-22.02,"profit":false},{"date":"2021-12-31","value":-45.72,"profit":false},{"date":"2022-12-31","value":-105.19,"profit":false},{"date":"2023-12-31","value":-93.86,"profit":false}]
Total Non-Operating Income/Expense(7.58M)35.00K(222.00K)706.00K2.48M[{"date":"2019-12-31","value":-305.98,"profit":false},{"date":"2020-12-31","value":1.41,"profit":true},{"date":"2021-12-31","value":-8.97,"profit":false},{"date":"2022-12-31","value":28.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income27.12M(5.95M)(12.48M)(28.18M)(24.22M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-21.94,"profit":false},{"date":"2021-12-31","value":-46,"profit":false},{"date":"2022-12-31","value":-103.89,"profit":false},{"date":"2023-12-31","value":-89.3,"profit":false}]
Income Taxes-(21.00K)77.00K(534.00K)(1.00)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-27.27,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-693.51,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes-(5.93M)(12.55M)(27.65M)(24.22M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-593000000,"profit":false},{"date":"2021-12-31","value":-1255500000,"profit":false},{"date":"2022-12-31","value":-2764600000,"profit":false},{"date":"2023-12-31","value":-2422099900,"profit":false}]
Income From Continuous Operations(27.12M)(11.61M)(12.48M)(27.65M)(24.22M)[{"date":"2019-12-31","value":-2712400000,"profit":false},{"date":"2020-12-31","value":-1160900000,"profit":false},{"date":"2021-12-31","value":-1247800000,"profit":false},{"date":"2022-12-31","value":-2764600000,"profit":false},{"date":"2023-12-31","value":-2422100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income27.12M(5.93M)(12.55M)(27.65M)(24.22M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-21.86,"profit":false},{"date":"2021-12-31","value":-46.29,"profit":false},{"date":"2022-12-31","value":-101.92,"profit":false},{"date":"2023-12-31","value":-89.3,"profit":false}]
EPS (Diluted)(63.20)(8.24)(1.18)(1.06)(1.12)[{"date":"2019-12-31","value":-6320,"profit":false},{"date":"2020-12-31","value":-824,"profit":false},{"date":"2021-12-31","value":-118,"profit":false},{"date":"2022-12-31","value":-106,"profit":false},{"date":"2023-12-31","value":-112.14,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CMMB
Cash Ratio 4.46
Current Ratio 4.57

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CMMB
ROA (LTM) -46.18%
ROE (LTM) -93.80%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CMMB
Debt Ratio Lower is generally better. Negative is bad. 0.22
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.78

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CMMB
Trailing PE NM
Forward PE 13.00
P/S (TTM) 0.00
P/B 1.94
EV/R 0.00
EV/Ebitda 0.33

FAQs

What is Chemomab Therapeutics Ltd DRC share price today?

Chemomab Therapeutics Ltd DRC (CMMB) share price today is $1.68

Can Indians buy Chemomab Therapeutics Ltd DRC shares?

Yes, Indians can buy shares of Chemomab Therapeutics Ltd DRC (CMMB) on Vested. To buy Chemomab Therapeutics Ltd DRC from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CMMB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Chemomab Therapeutics Ltd DRC be purchased?

Yes, you can purchase fractional shares of Chemomab Therapeutics Ltd DRC (CMMB) via the Vested app. You can start investing in Chemomab Therapeutics Ltd DRC (CMMB) with a minimum investment of $1.

How to invest in Chemomab Therapeutics Ltd DRC shares from India?

You can invest in shares of Chemomab Therapeutics Ltd DRC (CMMB) via Vested in three simple steps:

  • Click on Sign Up or Invest in CMMB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Chemomab Therapeutics Ltd DRC shares
What is Chemomab Therapeutics Ltd DRC 52-week high and low stock price?

The 52-week high price of Chemomab Therapeutics Ltd DRC (CMMB) is $2.55. The 52-week low price of Chemomab Therapeutics Ltd DRC (CMMB) is $0.45.

What is Chemomab Therapeutics Ltd DRC price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Chemomab Therapeutics Ltd DRC (CMMB) is

What is Chemomab Therapeutics Ltd DRC price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Chemomab Therapeutics Ltd DRC (CMMB) is 1.94

What is Chemomab Therapeutics Ltd DRC dividend yield?

The dividend yield of Chemomab Therapeutics Ltd DRC (CMMB) is 0.00%

What is the Market Cap of Chemomab Therapeutics Ltd DRC?

The market capitalization of Chemomab Therapeutics Ltd DRC (CMMB) is $30.55M

What is Chemomab Therapeutics Ltd DRC’s stock symbol?

The stock symbol (or ticker) of Chemomab Therapeutics Ltd DRC is CMMB

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top